ORIGINAL RESEARCH article
Front. Oncol., 29 October 2020
Sec. Neuro-Oncology and Neurosurgical Oncology
Volume 10 - 2020 | https://doi.org/10.3389/fonc.2020.569584
RETRACTED: LOXL2 Upregulation in Gliomas Drives Tumorigenicity by Activating Autophagy to Promote TMZ Resistance and Trigger EMT
- QZ
Qing Zhang 1
- LY
Lianhe Yang 2
- GG
Gefei Guan 1
- PC
Peng Cheng 1
- WC
Wen Cheng 1
- AW
Anhua Wu 1*
1. Department of Neurosurgery, The First Hospital of China Medical University, Shenyang, China
2. Department of Pathology, First Affiliated Hospital and College of Basic Medical Sciences of China Medical University, Shenyang, China
Summary
Citation
Zhang Q, Yang L, Guan G, Cheng P, Cheng W and Wu A (2020) RETRACTED: LOXL2 Upregulation in Gliomas Drives Tumorigenicity by Activating Autophagy to Promote TMZ Resistance and Trigger EMT. Front. Oncol. 10:569584. doi: 10.3389/fonc.2020.569584
Received
04 June 2020
Accepted
05 October 2020
Published
29 October 2020
Volume
10 - 2020
Edited by
Maria Caffo, University of Messina, Italy
Reviewed by
Xin Shang, Shandong University, China; Shweta Tiwary, National Institutes of Health (NIH), United States
Updates
This article was submitted to Neuro-Oncology and Neurosurgical Oncology, a section of the journal Frontiers in Oncology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.